These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6382529)

  • 1. Bladder defense mechanisms against urinary tract infections.
    Schaeffer AJ
    Semin Urol; 1983 May; 1(2):106-13. PubMed ID: 6382529
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of soluble virulence factor by Escherichia coli.
    Mostafavi M; Stein PC; Parsons CL
    J Urol; 1995 May; 153(5):1441-3. PubMed ID: 7714961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New aspects of pathogenesis of lower urinary tract infections.
    Sobel JD
    Urology; 1985 Nov; 26(5 Suppl):11-6. PubMed ID: 3904135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization against urinary tract infections.
    Uehling DT; Jensen J; Balish E
    J Urol (Paris); 1985; 91(1):23-6. PubMed ID: 3900224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host defense mechanisms in the urinary tract.
    Kaye D
    Urol Clin North Am; 1975 Oct; 2(3):407-22. PubMed ID: 242105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of uropathogenic Escherichia coli with host uroepithelium.
    Kau AL; Hunstad DA; Hultgren SJ
    Curr Opin Microbiol; 2005 Feb; 8(1):54-9. PubMed ID: 15694857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of the bladder mucosa.
    Schlager TA; Lohr JA; Hendley JO
    Urol Res; 1993; 21(5):313-7. PubMed ID: 8279086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immunization of bacterial adherence to urothelium.
    Uehling DT; Mizutani K; Balish E
    Invest Urol; 1978 Sep; 16(2):145-7. PubMed ID: 361628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder defense mechanism.
    Mulholland SG; Parsons CL; Shrom SH; Murphy JJ
    Trans Am Assoc Genitourin Surg; 1976; 68():83-6. PubMed ID: 801214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract.
    Anders HJ; Patole PS
    Nephrol Dial Transplant; 2005 Aug; 20(8):1529-32. PubMed ID: 15941847
    [No Abstract]   [Full Text] [Related]  

  • 12. The primary antibacterial defense mechanism of the bladder.
    Parsons CL; Greenspan C; Mulholland SG
    Invest Urol; 1975 Jul; 13(1):72-8. PubMed ID: 1095522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiology. Pods invade infected bladders.
    Ferber D
    Science; 2003 Jul; 301(5629):31. PubMed ID: 12843366
    [No Abstract]   [Full Text] [Related]  

  • 14. Bladder surface mucin. Examination of possible mechanisms for its antibacterial effect.
    Parsons CL; Shrom SH; Hanno PM; Mulholland SG
    Invest Urol; 1978 Nov; 16(3):196-200. PubMed ID: 30735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the bladder defense mechanism by immunization.
    Uehling DT; Wolf L
    Invest Urol; 1969 Mar; 6(5):520-6. PubMed ID: 4887493
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside.
    Aronson M; Medalia O; Schori L; Mirelman D; Sharon N; Ofek I
    J Infect Dis; 1979 Mar; 139(3):329-32. PubMed ID: 376757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofluorescence studies of the bladder defense mechanism. I. Localization of Escherichia coli in the human bladder.
    Drach GW; Cox CE
    J Am Geriatr Soc; 1967 Dec; 15(12):1114-24. PubMed ID: 4862355
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.
    Anderson GG; Dodson KW; Hooton TM; Hultgren SJ
    Trends Microbiol; 2004 Sep; 12(9):424-30. PubMed ID: 15337164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
    Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
    J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P fimbria-specific B cell responses in patients with urinary tract infection.
    Kantele A; Möttönen T; Ala-Kaila K; Arvilommi HS
    J Infect Dis; 2003 Dec; 188(12):1885-91. PubMed ID: 14673769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.